Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 18834855)

  • 1. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
    Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
    Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells.
    Kojima K; Ohhashi R; Fujita Y; Hamada N; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Aug; 373(3):423-8. PubMed ID: 18573234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
    Li J; Chen Y; Zhao J; Kong F; Zhang Y
    Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-34 family in cancer and apoptosis.
    Hermeking H
    Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
    Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.
    Lizé M; Pilarski S; Dobbelstein M
    Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
    Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
    Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
    Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.
    Audrito V; Vaisitti T; Rossi D; Gottardi D; D'Arena G; Laurenti L; Gaidano G; Malavasi F; Deaglio S
    Cancer Res; 2011 Jul; 71(13):4473-83. PubMed ID: 21565980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
    Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
    Feinberg-Gorenshtein G; Avigad S; Jeison M; Halevy-Berco G; Mardoukh J; Luria D; Ash S; Steinberg R; Weizman A; Yaniv I
    Genes Chromosomes Cancer; 2009 Jul; 48(7):539-43. PubMed ID: 19373781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T; Li D; Sha J; Sun P; Huang Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.